Contribution: Industrial Research Assistance Program – Contributions to Firms
Pegasus Biotech Incorporated
$298,514.00
BPE Technology Development
FY 2022-23 · 2023-01-02
Summary
Pegasus Biotech is developing the process and analytical methods to commercialize the BPE plasmid technology as a DNA plasmid production platform.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Charlottetown|Charlottetown, Prince Edward Island, Canada
Recipient Type
For-profit organization
Business Number
760829879
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2023-01-02 | 2022-23 | $298,514.00 |
| 1 | 2023-01-02 | 2022-23 | $298,514.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 29 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 29 jours.
Agreement End Date
2024-02-29
Agreement Number
999756
Agreement Start Date
2023-01-02
Agreement Title
BPE Technology Development
Agreement Title (French)
Développement de la technologie BPE
Agreement Type
Contribution
Agreement Value
$298,514.00
Amendment Date
2023-12-14
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Pegasus Biotech is developing the process and analytical methods to commercialize the BPE plasmid technology as a DNA plasmid production platform.
Description (French)
Pegasus Biotech développe le processus et les méthodes analytiques pour commercialiser la technologie plasmidique BPE comme plateforme de production de plasmides d’ADN.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Charlottetown
Federal Riding (French)
Charlottetown
Federal Riding Number
11002
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
760829879
Recipient City
Charlottetown|Charlottetown
Recipient Country
CA
Recipient Legal Name
Pegasus Biotech Incorporated
Recipient Postal Code
C1A 4P3
Recipient Province or Territory
PE
Recipient Type
F
Reference Number
172-2022-2023-Q4-999756
